围手术期抗血小板治疗策略

Perioperative strategies for antiplatelet drug use

目前由于心脑血管疾病的增多,越来越多的患者应用抗血小板药物作为一级、二级预防,尤其是接受心脏手术后的病人更需要长期接受抗血小板药物治疗。但是,当这些病人需要手术治疗时,术前充分地评估患者心脑血管血栓事件的风险和术后抗血小板药物引起的出血风险至关重要。

At present, with the increasing in cardiovascular and cerebrovascular diseases, more and more patients use antiplatelet drugs for primary or secondary prevention, especially for the patients undergoing the cardiac surgery who need long-term antiplatelet drug therapy. But when such patients require surgery, it is important to evaluate the preoperative cardiovascular and cerebrovascular events risk and antiplatelet drug-induced bleeding risk in postoperative period. According to the risk classification, we decide how to use the antiplatelet drug therapy during the perioperative period and essentially protect the security of the antiplatelet drug therapy.